`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`TARO PHARMACEUTICALS U.S.A., INC.,
`Petitioner,
`
`v.
`
`APOTEX TECHNOLOGIES, INC.,
`Patent Owner
`
`
`
`U.S. Patent No. 7,049,328 B2
`
`
`Case No.: IPR2017-01446
`
`
`PETITIONER’S MOTION TO SEAL
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. §§ 42.14 and 42.54, Petitioner Taro Pharmaceuticals
`
`USA, Inc. respectfully requests that the Board seal (1) Petitioner’s Motion to Compel
`
`Routine Discovery, or in the Alternative, for Additional Discovery (“the Motion”),
`
`(2) Exhibits 1037-1045 and 1047-1049 that accompany the Motion, and (3) Exhibit
`
`1036, which is a transcript of the March 23, 2018 telephone conference in which the
`
`parties and the Board discussed the Motion.
`
`The parties have conferred and agreed to the provisions of the Modified
`
`Default Standing Protective Order set forth in Exhibit 1051, and have stipulated to be
`
`bound by its terms. Ex. 1050 shows the proposed modifications from the Default
`
`Standing Protective Order to which the parties have stipulated, in redline. The
`
`Modified Default Standing Protective Order provides:
`
`A party may file documents or information with the Board under seal,
`
`together with a non-confidential description of the nature of the
`
`confidential information that is under seal and the reasons why the
`
`information is confidential and should not be made available to the
`
`public. The submission shall be treated as confidential and remain
`
`under seal, unless, upon motion of a party and after a hearing on the
`
`issue, or sua sponte, the Board determines that the documents or
`
`information do not to qualify for confidential treatment.
`
`
`
`1
`
`
`
`(Ex. 1051 (Modified Default Standing Protective Order).)
`
`The Motion refers to information contained in Exhibits 1037-1045 and 1047-
`
`1049, which are documents that Patent Owner Apotex Technologies, Inc. has
`
`designated as Highly Confidential pursuant to the Stipulated Protective Order entered
`
`in the concurrent district court case, ApoPharma Inc. v. Taro Pharmaceutical
`
`Industries, Ltd., Case No. 2:16-cv-00528 (E.D.Tex.). Petitioner therefore filed the
`
`Motion under seal, along with a publicly-available redacted version of the Motion.
`
`Petitioner also filed Exhibits 1036-1045 and 1047-1049 under seal.
`
`Good Cause Exists for Sealing the Documents
`
`I.
`Although “the default rule is that all papers filed in an inter partes review are
`
`open and available for access by the public,” a party may file a motion with the
`
`Board to seal confidential information that is protected from disclosure. See Garmin
`
`Int’l, Inc. v. Cuozzo Speed Techs., LLC, IPR2012-00001, Paper No. 34 (PTAB Mar.
`
`14, 2013). “The standard for granting a motion to seal is ‘for good cause.’” Id.
`
`(quoting 37 C.F.R. § 42.54). The Office Patent Trial Practice Guide, 77 Fed. Reg.
`
`48756, 48760 (Aug. 14, 2012), states that the “rules identify confidential information
`
`in a manner consistent with Federal Rule of Civil Procedure 26(c)(1)(G), which
`
`provides for protective orders for trade secret or other confidential research,
`
`development, or commercial information.”
`
`
`
`2
`
`
`
`Petitioner is filing a Motion to Compel Routine Discovery, or in the
`
`Alternative, for Additional Discovery, which refers to materials that Patent Owner
`
`has designated as “Highly Confidential” under the Stipulated Protective Order filed
`
`in the concurrent district court case. Those materials are being filed with the Motion.
`
`(Exs. 1037-1045 and 1047-1049.) Petitioner is seeking to seal these documents and
`
`the Motion, and based on Patent Owner’s designation in the ongoing district court
`
`litigation, there is good cause to seal these documents.
`
`Petitioner is also filing Exhibit 1036, which is the transcript of the telephonic
`
`conference in which the parties and the Board discussed the Motion. Patent Owner
`
`designated that transcript as confidential, and there is therefore good cause to seal
`
`this document.
`
`II. Certification of Conference with Opposing Party Pursuant to 37
`C.F.R. § 42.54
`
`The parties have conferred and Patent Owner does not oppose this motion.
`
`THEREFORE, Petitioner respectfully requests that the Board grant this Motion to
`
`Seal.
`
`
`
`
`
`
`
`
`
`
`
`3
`
`
`
`By:
`/Huiya Wu/
`Huiya Wu (Reg. No. 44,411)
`Sarah Fink (Reg. No. 64,886)
`
`Counsel for Petitioner
`
`GOODWIN PROCTER, LLP
`The New York Times Building
`620 Eighth Avenue
`New York NY 10018
`hwu@goodwinlaw.com
`
`Respectfully submitted,
`
`
`
`Date: April 16, 2018
`
`
`
`
`
`
`
`4
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that, on April 16, 2018, I caused a true and correct copy of
`
`the foregoing materials: PETITIONER’S MOTION TO SEAL to be served via
`
`electronic mail on the following attorneys of record:
`
`
`
`
`
`
`
`By:
`/Sarah Fink/
`Sarah Fink (Reg. No. 64,886)
`
`
`
`W. Blake Coblentz
`Aaron S. Lukas
`Barry Golob
`
`Email:
`wcoblentz@cozen.com
`alukas@cozen.com
`bgolob@cozen.com
`
`
`
`
`
`
`
`
`
`
`
`